LADENBURG THALMANN FINANCIAL SERVICES INC. - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$03000.0%0.00%
Q2 2019$03000.0%0.00%
Q1 2019$03000.0%0.00%
Q4 2018$0
-100.0%
3000.0%0.00%
Q3 2018$1,0003000.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 1,889,652$18,462,0001.22%
WALL STREET ASSOCIATES 250,000$2,442,0000.47%
Eventide Asset Management 403,912$3,946,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 485,000$4,738,0000.18%
J. Goldman & Co LP 170,000$1,661,0000.14%
QVT Financial LP 363,292$3,549,0000.12%
Kinsight, LLC 10,053$98,0000.07%
Welch Group, LLC 33,769$330,0000.06%
Visium Asset Management, LP 436,336$4,263,0000.06%
Candriam S.C.A. 135,300$1,322,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders